top of page

Psychedelic-Assisted Therapies Enter Addiction Treatment Conversation

11 minutes ago
2 min read

Psilocybin is not FDA-approved to treat substance use disorders. The findings below come from clinical research and do not support self-administering psilocybin or other psychedelics. Any use of these substances for treatment should occur only under a healthcare provider's guidance and as part of an appropriate medical protocol.


Psilocybin has recently been evaluated in clinical trials as a possible treatment for several substance use disorders, including smoking cessation and cocaine use disorder. The compound has also been studied for mental health conditions such as post-traumatic stress disorder (PTSD).


In the smoking cessation study, researchers compared long-term abstinence rates among adult smokers who received a single dose of psilocybin combined with cognitive behavioral therapy (CBT) with those who received CBT and 8 to 10 weeks of nicotine patch treatment (Johnson et al., 2026). Psilocybin was administered under the supervision of healthcare professionals in a controlled laboratory setting, followed by multiple debriefing sessions. At follow-up, 52% of participants who received psilocybin and CBT achieved 7-day smoking abstinence, and 40% maintained prolonged abstinence at six months.


A second study examined psilocybin as a treatment for cocaine use disorder among individuals motivated to quit (Hendricks et al., 2026). Participants received either a single dose of psilocybin or an active placebo, and all participants also received CBT. Treatment was delivered during a full-day clinic visit and followed by five debriefing and integration sessions. Compared with the placebo group, participants who received psilocybin experienced significantly more cocaine-free days, higher rates of complete abstinence, and a lower risk of relapse over a six-month period.


Together, these studies highlight psilocybin’s promising area for further research as a novel treatment for multiple substance use disorders. In both clinical trials, participants achieved higher short- and long-term abstinence rates than have been reported with other interventions, including medications and behavioral therapies. These findings are especially encouraging for cocaine use disorder, for which there are currently no FDA-approved medications.


The results reflect psilocybin delivered as part of structured clinical research, with screening, professional oversight, and follow-up. They do not support self-administration of psilocybin or other psychedelics to treat smoking, cocaine use, or other substance use disorders. A substance’s availability through a dispensary does not mean it has been evaluated or approved as a treatment for these conditions.


Moving forward, developing appropriate treatment protocols for psilocybin in substance use disorders will be essential. The interventions used in these studies were intensive, individualized, and designed to carefully screen and support participants. Expanding psilocybin treatment to larger populations will require further research on optimal dosing, the intensity of preparation and follow-up sessions, its use in more diverse patient populations with co-occurring conditions, and the training needed for healthcare providers to safely and effectively deliver treatment.


The Articles

Johnson, M. W., Naudé, G. P., Hendricks, P. S., & Garcia-Romeu, A. (2026). Psilocybin or Nicotine Patch for Smoking Cessation: A Pilot Randomized Clinical Trial. JAMA network open, 9(3), e260972. https://doi.org/10.1001/jamanetworkopen.2026.0972


Hendricks, P. S., Lappan, S. N., Shelton, R. C., Lahti, A. C., Cropsey, K. L., Johnson, M. W., Bradley, M., Simonsson, O., Davis, L. L., Grossman, D. H., & Ortiz, C. E. (2026). Psilocybin in the Treatment of Cocaine Use Disorder: A Randomized Clinical Trial. JAMA network open, 9(5), e2611029. https://doi.org/10.1001/jamanetworkopen.2026.11029

APF_logo_Black_edited.png
CONTACT US

(301) 769-5966

info@addictionpolicy.org

​

909 Rose Avenue, Suite 400, North Bethesda, MD 20852

Addiction Policy Forum is a nonprofit organization working to eliminate addiction as a major health problem.

  • Facebook
  • Twitter
  • Youtube
  • Instagram

©2024 Addiction Policy Forum. All rights reserved.

Rockville, Maryland United States

bottom of page